Sulfanilides
eMolecules S 3304 | 203640-27-1 | MFCD22200275 | 50mg
Ambeed | S 3304 | 50mg | 525023885 | A123766 | | 203640-27-1 | MFCD22200275 | 464.550 | C24H20N2O4S2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 3,3,3-Trifluoropropane sulfonamide | 1033906-44-3 | MFCD08704575 | 25g
Oakwood Chemicals | 3,3,3-Trifluoropropane sulfonamide | 25g | 480131332 | 044584 | | 1033906-44-3 | MFCD08704575 | 177.140 | C3H6F3NO2S
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules (2E)-3-(2,5-Dimethoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one | 151135-94-3 | | 100mg
Oakwood Chemical | (2E)-3-(2,5-Dimethoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one | 100mg | 537713722 | 191039 | | 151135-94-3 | | 284.311 | C17H16O4
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Reparixin L-lysine salt | 266359-93-7 | C20H35N3O5S | 2 MG
Reparixin L-lysine salt is an allosteric inhibitor of chemokine receptor 1/2 (CXCR1/2) activation. It is a potent functional inhibitor of CXCL8-induced biological activities on human PMNs, showing approximately 400-fold selectivity for CXCR1 over CXCR2. It acts as a non-competitive allosteric inhibitor of IL-8 receptors and is currently involved in several clinical trials for various conditions. This product is for research use only.
- Allosteric inhibitor of chemokine receptor 1/2 (CXCR1/2) activation
- Potent functional inhibitor of CXCL8-induced biological activities on human PMNs
- Approximately 400-fold selectivity for CXCR1 over CXCR2
- Non-competitive allosteric inhibitor of IL-8 receptors
- Involved in clinical trials for various conditions
- For research use only
Medchemexpress LLC (R)-BAY-899 | 2988191-40-6 | 99.9% | 50 MG
(R)-BAY-899 is the R-enantiomer of BAY-899, an orally active and selective luteinizing hormone receptor (LH-R) antagonist. It exhibits IC50s of 185 nM for human LH and 46 nM for rat LH.
- Selective luteinizing hormone receptor antagonist
- Orally active
- IC50s: 185 nM for hLH, 46 nM for rLH
- Molecular weight: 459.45
- Chemical formula: C25H19F2N5O2
- Appearance: Off-white to light yellow solid
- Storage as powder: -20°C for 3 years, 4°C for 2 years
- Storage in solvent: -80°C for 6 months, -20°C for 1 month
- Solubility in DMSO: 125 mg/mL (272.06 mM)
- Solubility (in vivo): ≥ 5 mg/mL in various protocols
Medchemexpress LLC O-3M3FBS | 313981-55-4 | 343.36 | 10 MG
o-3M3FBS acts as the negative control for m-3M3FBS. It inhibits inward and outward currents through mechanisms independent of PLC, functioning antagonistically. Additionally, it causes an increase in [Ca2+]i in an agonistic manner.
- Inhibits inward and outward currents independently of PLC
- Acts antagonistically to certain mechanisms
- Increases [Ca2+]i agonistically
- Target: Calcium Channel
- Pathway: Membrane Transporter/Ion Channel; Neuronal Signaling
Medchemexpress LLC HY-B0109A 10mg Medchemexpress, Dorzolamide (hydrochloride) CAS:130693-82-2 Purity:>98%
Medchemexpress, HY-B0109A 10mg Dorzolamide (hydrochloride) CAS:130693-82-2 Dorzolamide (L671152) hydrochloride is a potent carbonic anhydrase II inhibitor, with IC50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity.
Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.